- Home
- MRSN vs BLIV Comparison
MRSN vs BLIV Comparison
Compare MRSN & BLIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- BLIV
- Stock Information
- Founded
- MRSN 2001
- BLIV 2014
- Country
- MRSN United States
- BLIV Singapore
- Employees
- MRSN N/A
- BLIV N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- BLIV
- Sector
- MRSN Health Care
- BLIV
- Exchange
- MRSN Nasdaq
- BLIV NYSE
- Market Cap
- MRSN 36.4M
- BLIV 39.8M
- IPO Year
- MRSN 2017
- BLIV 2025
- Fundamental
- Price
- MRSN $0.35
- BLIV $3.04
- Analyst Decision
- MRSN Buy
- BLIV
- Analyst Count
- MRSN 3
- BLIV 0
- Target Price
- MRSN $4.00
- BLIV N/A
- AVG Volume (30 Days)
- MRSN 3.1M
- BLIV 736.0K
- Earning Date
- MRSN 05-08-2025
- BLIV 01-01-0001
- Dividend Yield
- MRSN N/A
- BLIV N/A
- EPS Growth
- MRSN N/A
- BLIV N/A
- EPS
- MRSN N/A
- BLIV N/A
- Revenue
- MRSN $40,497,000.00
- BLIV $1,915,838.00
- Revenue This Year
- MRSN N/A
- BLIV N/A
- Revenue Next Year
- MRSN N/A
- BLIV N/A
- P/E Ratio
- MRSN N/A
- BLIV N/A
- Revenue Growth
- MRSN 9.88
- BLIV N/A
- 52 Week Low
- MRSN $0.26
- BLIV $2.80
- 52 Week High
- MRSN $3.83
- BLIV $6.40
- Technical
- Relative Strength Index (RSI)
- MRSN 44.90
- BLIV N/A
- Support Level
- MRSN $0.31
- BLIV N/A
- Resistance Level
- MRSN $0.40
- BLIV N/A
- Average True Range (ATR)
- MRSN 0.05
- BLIV 0.00
- MACD
- MRSN 0.01
- BLIV 0.00
- Stochastic Oscillator
- MRSN 68.09
- BLIV 0.00
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.